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Background: Early signs interventions show promise but could be further developed. A recent review suggested
that ‘basic symptoms’ should be added to conventional early signs to improve relapse prediction. This study
builds on preliminary evidence that basic symptoms predict relapse and aimed to: 1. examinewhich phenomena
participants report prior to relapse and how they describe them; 2. determine the best way of identifying pre-re-
lapse basic symptoms; 3. assess current practice by comparing self- and casenote-reported pre-relapse experi-
ences.
Methods: Participants with non-affective psychosis were recruited from UK mental health services. In-depth in-
terviews (n= 23), verbal checklists of basic symptoms (n= 23) and casenote extracts (n= 208) were analysed
using directed content analysis and non-parametric statistical tests.
Results: Three-quarters of interviewees reported basic symptoms and all reported conventional early signs and
‘other’ pre-relapse experiences. Interviewees provided rich descriptions of basic symptoms. Verbal checklist in-
terviews asking speciﬁcally about basic symptoms identiﬁed these experiencesmore readily than open questions
during in-depth interviews. Only 5% of casenotes recorded basic symptoms; interviewees were 16 times more
likely to report basic symptoms than their casenotes did.
Conclusions: The majority of interviewees self-reported pre-relapse basic symptoms when asked speciﬁcally
about these experiences but very few casenotes reported these symptoms. Basic symptoms may be potent pre-
dictors of relapse that clinicians miss. A self-report measure would aid monitoring of basic symptoms in routine
clinical practice and would facilitate a prospective investigation comparing basic symptoms and conventional
early signs as predictors of relapse.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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1. Introduction
Relapse of psychosis is common (Robinson et al., 1999) and predicts
distress (Maclean, 2008), impaired vocational and interpersonal func-
tioning (Gumley and Schwannauer, 2006), long-term deterioration
(Wiersma et al., 1998) and suicide (Appleby, 1992). It frequently results
in hospital admission, the single biggest expense in schizophrenia's an-
nual UK National Health Service cost of over £3.9 billion (Almond et al.,
2004; Andrew et al., 2012), the USA equivalent being $22.7 billion (Wu
et al., 2005). Interventions using early signs of deterioration to prompt
timely preventative action can prevent relapse (Gumley et al., 2003;
Herz et al., 2000; Lee et al., 2010), but could be further developed.
Predictive validity of checklists such as the Early Signs Scale (ESS;
Birchwood et al., 1989) could be improved by adding other
hypothesised predictors such as basic symptoms (Eisner et al., 2013;
Gumley et al., 2015).
‘Basic symptoms’ are subtle, sub-clinical disturbances in one's expe-
rience of oneself and the world that prospectively predict ﬁrst episodes
of psychosis (FEP) (Fusar-Poli et al., 2012; Schultze-Lutter et al., 2007).
Typical basic symptoms include: perceptual changes such as colours' in-
creased vividness; mild subjective cognitive problems; decreased toler-
ance of stressors. Overlap between lists of conventional early signs (e.g.
ESS) and basic symptoms (e.g. Schizophrenia Proneness Index, Adult
Version, SPI-A; Schultze-Lutter et al., 2007) is small (b5%). There is pre-
liminary evidence that basic symptoms predict relapses of psychosis
(Bechdolf et al., 2002; Gaebel and Riesbeck, 2014).
We aimed to investigate whether basic symptoms could be used to
predict relapse in routine clinical practice and to compare them to
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conventional early signs in anticipation of developing and prospectively
testing a basic symptoms measure. Using data from in-depth inter-
views, verbal checklists of basic symptoms and casenote extracts, we
addressed the following research questions: 1.Which pre-relapse experi-
ences (early signs, basic symptoms, ‘other’) do participants report and how
do they describe them?; 2.What is the best way of identifying basic symp-
toms: in-depth interview or verbal checklist?; 3.Which pre-relapse experi-
ences (early signs, basic symptoms, ‘other’) are reported in casenotes?
2. Methods
2.1. Ethics
Ethical approval was obtained from the Liverpool Central research
ethics committee (ref: 12/NW/0091).
2.2. Which pre-relapse experiences do participants report?What is the best
way of identifying basic symptoms?
2.2.1. Participants
Sample A: 23 patients were purposively sampled to include a range
of characteristics from three NHS (National Health Service) Mental
Health Trusts between May and November 2012. Inclusion criteria
were: aged over 18 years; primary clinical diagnosis of non-affective
psychosis (APA, 2000); admission to crisis team or inpatient unit in
the past 6months for acute psychosis; prescribed antipsychoticmedica-
tion; no illicit drug use, or alcohol abuse or dependence, during the pre-
relapse period; informed consent.
2.2.2. Data collection
In-depth interview: open questions explored events, feelings and
experiences in the three months prior to the most recent relapse
(topic guide available on request). Verbal checklist of basic symptoms:
assessed experiences of basic symptoms in the three months prior to
the recent relapse, based on the SPI-A, (Schultze-Lutter et al., 2007).
The SPI-A (56 items) includes two overlapping lists of basic symptoms
that predict FEP, ‘COGDIS’ (Cognitive Disturbances, 9 items) and
‘COPER’ (Cognitive-Perceptive basic symptoms, 14 items), in addition
to 38 other basic symptoms (Schultze-Lutter et al., 2007). All interviews
were audio-recorded and transcribed verbatim.
2.3. Which pre-relapse experiences are reported in casenotes?
2.3.1. Participants
Sample A: 21/23 in-depth interview and verbal checklist partici-
pants consented to their casenotes being examined. Sample B: 187 pa-
tients (approximately 10% of those eligible) were randomly selected
(stratiﬁed by clinical team) from those aged over 18with a clinical diag-
nosis of non-affective psychosis (WHO, 1992) and attending Communi-
ty Mental Health Teams in one NHS Mental Health Trust in November
2010. Since datawas obtained from a pseudo-anonymised dataset gath-
ered for an audit, separate ethical approval and patient consent were
not required (BMA, 2014).
2.3.2. Data collection
Five research assistants examined participants' electronic casenotes
(n=208) and extracted demographic information and verbatimquota-
tions from the section of the most recent CPA review entitled “early
warning signs”, “relapse indicators” or “crisis plan”.
2.4. Analysis
2.4.1. Directed content analysis
Directed content analysis (Hsieh and Shannon, 2005) was used to
quantify pre-relapse experiences. Supplementary material Section B
gives details of this process. All transcripts were coded according to
the stage of the relapse process being described (pre-relapse, during re-
lapse, unrelated to relapse). Pre-relapse experiences were then coded,
with codes grouped into early signs, basic symptoms and ‘other’ pre-re-
lapse experiences. Inter-rater reliability was assessed (supplementary
material Section B).
2.4.2. Statistical analysis
Non-parametric statistics were used due to the relatively small size
of the interview sample (see supplementary material Section B). For
all analyses, ﬁndings were considered signiﬁcant at p = 0.05.
3. Results
3.1. Sample characteristics
Table 1 shows demographic and clinical characteristics of the two
samples.
3.2. Inter-rater reliability
Casenote data extraction:mean percentage agreementwith consen-
sus extractionwas 95.7% after training and 91.4% during data collection.
Stage-of-relapse coding: weighted kappa was 0.74. Pre-relapse experi-
ence coding: ICCs and kappas were calculated for three types of item
(early signs, basic symptoms, other) and three types of data (in-depth
interviews, verbal checklist, casenotes). ICCs all exceeded 0.72 and
kappa values all exceeded 0.60.
3.3. Which pre-relapse experiences do participants report and how do they
describe them?
3.3.1. Estimated sensitivity (early signs, basic symptoms, ‘other’)
Three-quarters (74%) of participants reported ≥ 1 basic symptom,
with all participants reporting both conventional early signs and
‘other’ pre-relapse experiences. Sensitivity here refers to the proportion
of relapses correctly identiﬁed by a putative predictor. Since all partici-
pants in the interview sample had relapsed, it equates to the proportion
reporting a particular pre-relapse experience (i.e. 74% for basic symp-
toms, 100% for early signs, 100% for ‘other’). No demographic or clinical
characteristics listed in Table 1 signiﬁcantly predicted reporting ≥ 1
basic symptom.
3.3.2. Number of pre-relapse experiences reported (early signs, basic symp-
toms, ‘other’)
Fig. 1 shows the number of basic symptoms, early signs and ‘other’
experiences reported to begin or increase pre-relapse. Participants re-
ported signiﬁcantly more (z = 3.12, p = 0.002) early signs (Median
= 5; IQR = 3,6) than they did basic symptoms (Median = 2, IQR =
0,5). However, 35% (6/17) of those reporting basic symptoms, reported
at least as many basic symptoms as they did conventional early signs.
Furthermore, reported pre-relapse experiences were idiosyncratic,
with a wide range of experiences reported (79 experiences) and most
(57%) reported by ≤2 participants.
3.3.3. Estimated speciﬁcity (basic symptoms only)
Fourteen participants reported that they experienced basic symp-
toms at times unrelated to relapse (with no increase prior to relapse).
Speciﬁcity, generally the proportion of non-cases correctly identiﬁed
by negative test values was estimated by the proportion of the sample
who did not report having experienced basic symptoms at times unre-
lated to relapse (39% for any basic symptoms; 70% for COGDIS; 61% for
COPER).
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3.3.4. Estimated receiver operating characteristic curve (basic symptoms
only)
Fig. 2 illustrates the relative sensitivity and speciﬁcity of basic symp-
toms based on available data from the current study. Sensitivity and
speciﬁcity were estimated, as described above, for any basic symptom,
COPER basic symptoms and COGDIS basic symptoms at thresholds of
1, 2, 3, 4 and 5 basic symptoms present. Predicting relapse using any
basic symptom was more sensitive but less speciﬁc than using a sub-
set such as COPER or COGDIS. Conversely, using a higher threshold
(e.g. 2 basic symptoms rather than 1) yielded a more speciﬁc but less
sensitive assessment of imminent relapse. Fig. 2 gives an approximation
of the area within which the ROC (Receiver Operating Characteristic)
curves may fall for the three groups of basic symptoms. Although
there are no points close to the top left corner of the graph (which
would indicate extremely good prediction of relapse), the points do
not straddle the line either suggesting that these groups of basic symp-
toms do have some predictive value. Visual inspection gives an overall
impression that using a threshold of ≥2 or ≥3 basic symptoms, or alter-
natively ≥ 2 COPER basic symptoms, may give a better balance of sensi-
tivity and speciﬁcity than using a threshold of ≥1 basic symptoms.
3.3.5. How did people describe basic symptoms?
The eighteen most frequently self-reported basic symptoms are
shown in Table 2, with example quotations. A further 15 basic symp-
toms, not listed in the table, were reported by only one participant
each. Thus 73% (33/45) of basic symptoms listed in the SPI-A were spe-
ciﬁcally identiﬁed as beginning or increasing during the period before
relapse, rather than at other times. The quotations from participants
(Table 2) provide rich, authentic descriptions of basic symptoms,
which will be used to design items for a self-report measure.
Table 1
Demographic and clinical characteristics of the two study samples.
Sample A (n = 23) Sample B (n = 187) Comparison of the two
samples
Frequency Percentage Frequency Percentage χ2 p
Age, mean (SD), U 38.4 (14.0) 45.0 (11.7) 2.42 0.016
Gender, n male 11 (47.8) 116 (62.0) 1.73 0.189
Diagnosis
Schizophrenia 17 (73.9) 159 (85.0)
Schizoaffective disorder 6 (26.1) 18 (9.6)
Other non-affective psychosis 0 (0.0) 10 (5.3)
Ethnic origin 0.83 0.863
Asian or Asian British 3 (13.0) 17 (9.1)
Black or Black British 3 (13.0) 33 (17.6)
White British 16 (69.6) 124 (66.3)
Other ethnic group 1 (4.3) 13 (6.9)
Living arrangement 3.37 0.353
Family or partner 9 (39.1) 59 (31.6)
Alone 11 (47.8) 69 (36.9)
Shared/supported accommodation 3 (13.0) 54 (28.9)
Homeless 0 (0.0) 4 (2.1)
Unknown 0 (0.0) 1 (0.5)
Level of family or carer contact 9.01 0.012
None 8 (34.8) 22 (11.8)
Low 8 (34.8) 44 (23.6)
High 7 (30.4) 96 (51.3)
Unknown 0 (0.0) 25 (13.4)
Note: descriptive statistics are N (%) and inferential statistic is χ2 unless otherwise speciﬁed.
Fig. 1. Number of basic symptoms, early signs and ‘other’ experiences reported pre-relapse in the in-depth interview or verbal checklist (n = 23), ranked by basic symptoms.
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3.4. What is the best way of identifying basic symptoms: in-depth interview
or verbal checklist?
Twice as many participants reported ≥ 1 basic symptom during the
verbal checklist (69.6%) than during the in-depth interview (34.8%), a
statistically signiﬁcant difference (χ2 = 6.40, p = 0.022). The number
of basic symptoms reported in the verbal checklist (Median = 2, IQR
= 0,3) was also signiﬁcantly higher (z = 2.87, p = 0.004) than in the
in-depth interview (Median = 0, IQR = 0,1).
3.5. Which pre-relapse experiences are reported in casenotes?
Table 3 shows the percentages of participants forwhom each type of
pre-relapse experience (basic symptoms, early sign, ‘other’)was report-
ed via self-report (in-depth interviews, verbal checklists) or in
casenotes, and the median number of experiences reported in each
case. As with the self-reported data, examination of individual items in-
dicated that although a large range of pre-relapse experiences was re-
ported in casenotes, half of these (34/68, 50%) were reported in ≤2
participants' casenotes.
Interviewees were signiﬁcantly more likely to self-report ≥ 1 early
sign, basic symptom or ‘other’ experience, respectively, than was re-
ported in their casenotes (Table 3). The largest difference was for
basic symptoms, with sixteen times more participants' self-reporting
basic symptoms (76.2% participants) than had them reported in
casenotes (4.8%). The number of self-reported basic symptoms and
‘other’ experiences was signiﬁcantly higher than in casenotes, whereas
the reported number of early signs did not differ between self-report
and casenotes (Table 3).
Table 3 also compares the two study samples in terms of casenote-
reported pre-relapse experiences. The samples did not differ in terms
of the proportion reporting each type of pre-relapse experience (basic
symptoms, early signs, ‘other’) or the number of these experiences re-
ported. The two samples also did not differ in terms of gender, ethnicity
or living situation (see Table 1), but the non-interview sample (B: n =
187)was signiﬁcantly older andmore likely to have high levels of family
contact than the interview sample (A: n = 23). Thus, the two samples
were largely comparable, with signiﬁcant differences apparent on only
2 of the 12 assessed variables.
4. Discussion
This study used 23 in-depth interview transcripts, 23 verbal check-
list transcripts and 208 casenote extracts to: i) examine which basic
symptoms occurred prior to relapse; ii) how these basic symptoms
were described in order to compare spontaneous and prompted self-re-
ported symptoms; and iii) compare self-reported experiences to those
assessed in clinical practice. Three-quarters of participants retrospec-
tively reported ≥ 1 basic symptom that began or increased prior to a re-
cent relapse. All participants reported ≥ 1 conventional early sign and
‘other’ pre-relapse experience. Although participants reported signiﬁ-
cantly more early signs than they did basic symptoms, a third of partic-
ipants who reported basic symptoms reported as many as they did
conventional early signs. Participants gave rich descriptions of basic
symptoms, but only when prompted.
Basic symptoms have been shown to predict FEP in continental Eu-
ropean samples (Fusar-Poli et al., 2012; Schultze-Lutter et al., 2007).
Only two previous studies (Bechdolf et al., 2002; Gaebel and Riesbeck,
2014) have investigated whether basic symptoms occurred prior to re-
lapse in those with established psychosis. A small, retrospective study
(Bechdolf et al., 2002) found basic symptoms reported prior to both de-
pressive and psychotic episodes, with differences in the content of basic
symptoms distinguishing a depressive from a psychotic episode. Unlike
the current study, only those with ICD-10 paranoid schizophrenia who
had no residual symptoms were included in the psychosis sample,
which limits the generalizability of the ﬁndings. More recently, a larger
study (Gaebel and Riesbeck, 2014) appears to have prospectively
assessed basic symptoms in those with a previous episode of psychosis.
Although the authors do not explicitly state that they examined basic
symptoms, they list ten items whose brief descriptions resemble the
COPER sub-scale of the SPI-A. Sensitivity (mean 12%) and speciﬁcity
Fig. 2.A descriptive ROC curve exploring the predictive value of different basic symptomcriteria (data labels indicate threshold number of basic symptomsused to estimate sensitivity and
speciﬁcity ﬁgures).
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(mean 97%) values for these 10 individual items provide some evidence
that basic symptoms occur prior to relapse. However, since no com-
bined predictive value for the COPER-like items is given, one cannot
draw strong conclusions about the value of basic symptoms as predic-
tors of relapse.
The current study shows that one can identify pre-relapse basic
symptoms in a UK sample of patients with chronic schizophrenia. Al-
though the current retrospective study cannot determine deﬁnitively
how well basic symptoms predict relapse, it does indicate that it is a
question worth further investigation. A prospective study comparing
the sensitivity and speciﬁcity of basic symptoms and conventional
early signs is warranted. Data from the current studywill inform the de-
velopment of a deﬁnitive prospective study in three speciﬁc ways: i) it
will help to determine the threshold number (and type) of basic symp-
toms required to count someone as a ‘case’ (i.e. predicted to have a re-
lapse); ii) it will inform the design of a self-report measure for
prospectively monitoring basic symptoms; iii) it lends weight to the
idea thatmonitoring an individualised ‘relapse signature’ is themost ef-
ﬁcient way of spotting early indicators of relapse (given the wide range
and idiosyncratic nature of reported pre-relapse experiences).
Estimated retrospective sensitivity of reporting ≥ 1 basic symptom
(74%) in the current studywas higher than themedian prospective sen-
sitivity (61%) of early signs measures in a recent review (Eisner et al.,
2013), but estimated speciﬁcity was lower (current study, 39%; review
median, 81%). This suggests that using ≥1 basic symptom is not the op-
timum threshold for caseness. Although there was insufﬁcient data to
perform a formal ROC analysis with probability testing, we plotted a de-
scriptive ROC curve to explore whether setting a higher threshold for
caseness (e.g. ≥3 basic symptoms) or deﬁning a smaller, more predic-
tive set of basic symptoms (e.g. COGDIS or COPER)would provide a bet-
ter balance of sensitivity and speciﬁcity. Visual inspection of the ROC
curve suggested that a threshold of ≥2 or ≥3 basic symptoms, or alterna-
tively ≥ 2 COPER basic symptoms, may give a better balance of sensitiv-
ity and speciﬁcity.
To monitor basic symptoms as part of a personalised relapse signa-
ture, clinicians need to identify which of these an individual experi-
enced prior to previous relapses. The best way of identifying pre-
relapse basic symptoms in the current study was a verbal checklist ask-
ing speciﬁcally about these experiences: twice as many participants
identiﬁed basic symptoms during verbal checklists than during in-
depth interviews. Firstly, thismay be because the in-depth interview re-
quired recall memory whereas the verbal checklist only used recogni-
tion memory, the latter being easier (Speer and Flavell, 1979) and
both being impaired in schizophrenia (Libby et al., 2013). Secondly, un-
like psychotic symptoms, patients are not commonly asked about basic
symptoms in a UK mental health service context. Aside from a small
number of Early Intervention Services assessing basic symptoms as pro-
dromal symptoms of FEP (e.g. Lancashire Early Assessment and Detec-
tion Clinic; Johnson, 2013), we know of very few clinical services in
the UKwho assess them. Participants in the current study (all receiving
care from UK mental health services) may not have spontaneously di-
vulged these experiences because they did not expect the interviewer
to be interested in them. Thirdly, patients may not recognise the expe-
riences as ‘symptoms’ per se and only begin to think their experience
is unusual when asked about them. Fourthly, some basic symptoms
may not be spontaneously divulged due to embarrassment, whereas
Table 2
Top pre-relapse basic symptoms reported by Sample A participants (n = 23) during the
in-depth interview or verbal checklist.
Item (Schizophrenia Proneness
Index item number)
Frequency Example quotation
Increased indecisiveness about
insigniﬁcant choices (C1)
5 “I don't know what I want half the
time. Even going to the shop I can't
even choose what sandwich I
want.”
Poor at multitasking (B1)a 5 “When I'm doing one thing, kind of
like my mind gets taken over by
that thing and I've got no more
room left for other things.”
Thought interference (C2)a,b 4 “I was up all night and… I just
started having random like weird
thoughts.”
Disturbance of receptive speech
(C4)a,b
3 “It wasn't something that was
their issue, it was my cognitive
ability to process it really rather
than it being they weren't saying
things the way that they should
have been.”
Increased stress reactivity (A1) 3 [Interviewer: what kind of things
would stress you out?] “Talking to
anyone, family or friend… couldn't
speak to anyone.”
Hypersensitivity to sounds (F4) 3 “I was really noticing birds, and it
felt like it was going straight into
my head, you know the noise”.
Straight things crooked or
double vision (O4.6)b
3 “Erm the clock sometimes, it
seems a bit bent”; “I mean like it,
it's straight but I just sometimes I
think it's bent.”; “I thought my
eyes must be playing up [laughs]”
Thought perseveration (O1)b 3 “Like an annoying thought that
you you know like you're trying to
focus on something and you really
can't focus on it cos you're got this
like silly thought in your head.”
Overly distracted by stimuli (B2) 2 “I'll be writing but then I'd get
drawn away from it to other things
whereas usually…I have a big
capacity for concentration solely
focusing on one thing and getting
it done”
Disturbances of olfactory,
gustatory or tactile perception
(O6)
2 “Sometimes when I taste food of
what other people make then I
just, it feels very like, like it's not
good, like it's expired or
something…it tastes really, like
nasty to me the food.”
Micropsia or macropsia (F3)b 2 “I remember saying that
something looked too big and
everyone was saying ‘there's
nothing wrong with it, it looks
ﬁne’ and I was going ‘it's too big,
it's too big, it's too big, it's too
big!’.”
Near or tele-vision (O4.1)b 2 “I get this feeling everything's
distant. And other things are near
at hand. This table…it could be
nearer or further away; nearer to
hand or further away.”
Shapes appear different or
distorted (O4.2)b
2 “Buildings and people look out of
shape.”
Decreased ability to distinguish
between ideas and perception
or fantasy and true memories
(O2)b
2 “In things that were almost
insigniﬁcant really like for
example, I'd think oh I made that, I
had that meal… then you go into
the fridge and it was still there and
you hadn't had it at all.”
Derealisation (O8)b 2 “The world seems strange to me”;
“I'm disconnected from the world.”
Slowed down thinking (B5) 2 “A slow thought would always
lead to a fast one.”
Thought blockages (C3)a,b 2 “A lot of times my thoughts do get
blank and it's taken me a long time
remembering.”
Table 2 (continued)
Item (Schizophrenia Proneness
Index item number)
Frequency Example quotation
Thought pressure (D3) 2 “My thoughts were actually pretty
random… my mind was all over
the place.”
a Item from Cognitive Disturbances (COGDIS) basic symptoms list.
b Item from Cognitive-Perceptive (COPER) basic symptoms list.
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being asked as part of a checklist, framed as a list of experiences that
people sometimes report before relapse, may normalise the experience.
The casenote data gives an insight into which pre-relapse experi-
ences are assessed in current practice. Only 5% of casenotes contained
≥ 1 basic symptom, with participants sixteen times more likely to self-
report a basic symptom than the casenotes. This was as predicted:
basic symptoms are not currently enquired about in British psychiatry,
especially not as early indicators of relapse, and clinicians are not gener-
ally trained to assess them. Furthermore, basic symptoms are subtle and
subjective, without outward signs that they are occurring, and patients
tend not to disclose them until prompted.
This study used directed content analysis to quantify the number of
basic symptoms, early signs and ‘other’ experiences reported during in-
depth interviews, verbal checklists and in casenotes. Although the cod-
ingmethodwas systematic, it was necessary for the coder to use judge-
ment at times. Nevertheless inter-rater reliability, assessed in 10% of
cases, was generally high. For all statistical analyses, ﬁndings were con-
sidered signiﬁcant at p = 0.05. Using a different threshold for signiﬁ-
cance may have resulted in different conclusions. There are limitations
speciﬁc to the self-reported data. Firstly, the sample for this data was
relatively small and purposively rather than randomly selected. We
used non-parametric statistics to account for the resultant non-normal-
ity of the data and compared the purposive sample to a much larger,
randomly selected sample. Since the two samples were largely compa-
rable, it is likely that the purposive sample provides a fairly good repre-
sentation of the experiences of this patient group. Secondly, data was
gathered retrospectively, whichmay have introduced bias; to minimize
this, only patients who had relapsed in the past six months were
interviewed. Thirdly, inherent in all studies where any two measures
are used serially, the ﬁrst measure could prime the second. We aimed
to minimize this effect by doing the in-depth interview, with its open
questions, ﬁrst and the verbal checklist of basic symptoms second.
Fourthly, there were limitations of the descriptive ROC curve (Fig. 2)
and the speciﬁcity data upon which it is based. There was insufﬁcient
data to perform a formal ROC analysis with probability testing; the esti-
mates of speciﬁcity are likely to be biased since they were based on in-
cidental reports during assessments aiming to elicit pre-relapse
experiences. Where high speciﬁcity is shown, this may be due to lack
of data rather than a genuinely highly speciﬁc assessment.
In summary, most interviewees self-reported pre-relapse basic
symptoms but very few casenotes reported them. Basic symptoms
may be potent predictors of relapse that clinicians miss. The best way
of identifying pre-relapse basic symptoms was a verbal checklist asking
speciﬁcally about these experiences. Use of a basic symptoms checklist
in clinical practice, in conjunction with an existing checklist of conven-
tional early signs, may yield a richer relapse signature. A prospective
study examining whether adding basic symptoms to conventional
early signs of relapse enhances predictive value is warranted. A self-
reportmeasure of basic symptoms could facilitate such a prospective in-
vestigation and aid monitoring of basic symptoms in routine clinical
practice.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.schres.2017.04.050. This work was supported by
the Medical Research Council (grant numbers MR/J500410/1, MR/
K500823/1, MR/K501311/1).
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